BCL2 and breast cancer: Accordingly, HeLa or MCF‐7 breast cancer cells treated with the B‐cell lymphoma 2 (Bcl‐2) gene siRNA‐loaded C‐dots, resulting in the inhibition of Bcl‐2 protein and the apoptosis of the cancer cells, Figure 8B.